Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sebastian Schneeweiss, Sc.D., M.D.

Co-Author

This page shows the publications co-authored by Sebastian Schneeweiss and Katsiaryna Bykov.
Connection Strength

1.758
  1. A Case-Crossover-Based Screening Approach to Identifying Clinically Relevant Drug-Drug Interactions in Electronic Healthcare Data. Clin Pharmacol Ther. 2019 07; 106(1):238-244.
    View in: PubMed
    Score: 0.209
  2. The Case-Crossover Design for Drug-Drug Interactions: Considerations for Implementation. Epidemiology. 2019 03; 30(2):204-211.
    View in: PubMed
    Score: 0.209
  3. Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis. Drug Saf. 2017 10; 40(10):923-932.
    View in: PubMed
    Score: 0.189
  4. Propensity Score Weighting Compared to Matching in a Study of Dabigatran and Warfarin. Drug Saf. 2017 02; 40(2):169-181.
    View in: PubMed
    Score: 0.181
  5. Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors. Am J Cardiol. 2017 02 15; 119(4):651-657.
    View in: PubMed
    Score: 0.178
  6. Comparison of Benefit-Risk Assessment Methods for Prospective Monitoring of Newly Marketed Drugs: A Simulation Study. Value Health. 2015 Dec; 18(8):1057-62.
    View in: PubMed
    Score: 0.166
  7. Prospective Benefit-Risk Monitoring of New Drugs for Rapid Assessment of Net Favorability in Electronic Health Care Data. Value Health. 2015 Dec; 18(8):1063-9.
    View in: PubMed
    Score: 0.165
  8. Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation. Thromb Haemost. 2015 Nov 25; 114(6):1277-89.
    View in: PubMed
    Score: 0.165
  9. Treatment dynamics of newly marketed drugs and implications for comparative effectiveness research. Value Health. 2013 Sep-Oct; 16(6):1054-62.
    View in: PubMed
    Score: 0.142
  10. Clinical Outcomes of Concomitant Use of Warfarin and Selective Serotonin Reuptake Inhibitors: A Multidatabase Observational Cohort Study. J Clin Psychopharmacol. 2017 Apr; 37(2):200-209.
    View in: PubMed
    Score: 0.046
  11. A unified framework for classification of methods for benefit-risk assessment. Value Health. 2015 Mar; 18(2):250-9.
    View in: PubMed
    Score: 0.039
  12. Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study. BMJ. 2013 Sep 19; 347:f5416.
    View in: PubMed
    Score: 0.036
  13. Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2013 Aug; 146(2):472-8.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.